Patient Story

Published Last updated

Stroke Female, 36 years old, February - March 2019

Summary

DiagnosisSexAgeNationality
StrokeFemale36 yearsBrazil
InjectionsCell typeAdmission dateDischarge date
6UCBSC2019-02-162019-03-19

Condition On Admission

The patient suffered from a stroke in July 2016. Before receiving stem cell treatment, the patient had mild spasticity in the upper right limb with loss of movement, muscle weakness in the upper and lower limbs, and she had difficulty speaking. Before starting treatment, the patient had given up hope on regaining arm movement.

Treatment Schedule

The patient received 6 umbilical cord blood-derived stem cell (UCBSC) packets by intravenous infusion (IV) and Intrathecal Injection (LP), as per the schedule below:

NumberDateCell TypeDelivery MethodSide Effects
12019-02-18UCBSCIntravenous Injectionnone reported
22019-02-22UCBSCIntrathecal Injectionnone reported
32019-02-25UCBSCIntrathecal Injectionnone reported
42019-03-01UCBSCIntrathecal Injectionnone reported
52019-03-05UCBSCIntrathecal Injectionnone reported
62019-03-08UCBSCIntravenous Injectionnone reported

Condition 3 months after treatment

3 months after the treatment​, significant improvements in speech and spasticity in the arms have already been noticed. The patient still had difficulty moving her arm and had no movements in her hand and fingers. However, her doctors believe that she has a good chance of improving more, taking into account the progress she has already made.

SymptomParents’ Assessment of Improvement
BalanceModerate improvements
CoordinationModerate improvements
Fine hand movementsSmall improvements
TremorsNot applicable
Control of movementModerate improvements
Muscle stiffnessNot applicable
SpeechModerate improvements
WalkingModerate improvements
FatigueSmall improvements
Internationally accredited

Held to global laboratory and biologics standards.